GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: ANASIA-124-1 is from a series of analogues that are being developed to target bacterial aminoacyl-tRNA synthetases (aaRSs) and claimed in patent WO2021123237A1 [1].
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Edmund G, Charlton MH, Finn PW, Jirgensons A, Skvorcova M, Veliks J, Grigorjeva L. (2021)
2-amino-n-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use. Patent number: WO2021123237A1. Assignee: Oxford Drug Design Ltd. Priority date: 18/12/2020. Publication date: 24/06/2021. |